~~<i id='EFC56B8E3C'><strike id='EFC56B8E3C'><tt id='EFC56B8E3C'><pre id='EFC56B8E3C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：focus 2025-09-30 08:01:01 - browse：24682

A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat — PATRICK T. FALLON/AFP via Getty Images

You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

He had a point.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： ASCO: AstraZeneca says CAR

hotspot

leisure time

explore

leisure time

Wikipedia

Asantibioticsresearchshrivels,thebraindrainawayfromthisfieldwillhavemanylabslookingthisempty.AdobeIn

WSS

Letters to First Opinion on caregivers, digital health, and more

15 die by electrocution after transformer explodes in northern India

Manchin plays down potential 3rd

See how much Covid

Letters to First Opinion on caregivers, digital health, and more

Flagship, Pfizer team up in deal worth up to $7 billion

hotspot

entertainment

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

NIH documents show early flaws of $1.6 billion long Covid program

In Memoriam: Notable people who died in 2023

Why you get paid to donate plasma but not blood

Apple is now the first public company to be valued at $3 trillion

More hospitals are billing patients as online messages surge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

hotspot

ASCO: AstraZeneca says CAR

Johnson & Johnson sues to stop Medicare negotiation

BridgeBio heart drug succeeds in pivotal study

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Intellia reports positive results for its CRISPR

leisure time

explore

leisure time

Wikipedia